医学
肺结核
死亡率
人口
人类免疫缺陷病毒(HIV)
免疫抑制
荟萃分析
儿科
人口学
免疫学
内科学
环境卫生
病理
社会学
作者
Fei‐Hong Hu,Xiaolei Tang,Meng‐Wei Ge,Yi‐Jie Jia,Wanqing Zhang,Wen Tang,Lu-Ting Shen,Wei Du,Xiaopeng Xia,Hong‐Lin Chen
出处
期刊:AIDS
[Ovid Technologies (Wolters Kluwer)]
日期:2024-03-15
卷期号:38 (8): 1216-1227
标识
DOI:10.1097/qad.0000000000003886
摘要
Objective: Children and adolescents with HIV infection are well known to face a heightened risk of tuberculosis. However, the exact mortality rates and temporal trends of those with HIV-tuberculosis (TB) co-infection remain unclear. We aimed to identify the overall mortality and temporal trends within this population. Methods: PubMed, Web of Science, and Embase were employed to search for publications reporting on the mortality rates of children and adolescents with HIV-TB co-infection from inception to March 2, 2024. The outcome is the mortality rate for children and adolescents with HIV-TB co-infection during the follow-up period. In addition, we evaluate the temporal trends of mortality. Results: During the follow-up period, the pooled mortality was 16% [95% confidence interval (CI) 13–20]. Single infection of either HIV or TB exhibit lower mortality rates (6% and 4%, respectively). We observed elevated mortality risks among individuals aged less than 12 months, those with extrapulmonary TB, poor adherence to ART, and severe immunosuppression. In addition, we observed a decreasing trend in mortality before 2008 and an increasing trend after 2008, although the trends were not statistically significant ( P = 0.08 and 0.2 respectively). Conclusions: Children and adolescents with HIV-TB co-infection bear a significant burden of mortality. Timely screening, effective treatment, and a comprehensive follow-up system contribute to reducing the mortality burden in this population.
科研通智能强力驱动
Strongly Powered by AbleSci AI